Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostic regulatory reform.
2025 · 4th Quarter (Oct 1 - Dec 31)
AMERICAN CLINICAL LABORATORY ASSN
Filed by AMERICAN CLINICAL LABORATORY ASSN.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 16, 2026
- Income
- Not reported
- Expenses
- $930,000.00
- Registrant
- AMERICAN CLINICAL LABORATORY ASSN
- Filing UUID
- c06b5cea-3cd3-4f14-aadf-cbb5a0aec4c4
- Termination date
- Not reported
Expense method: C
Literal source text
Lobbying issues and bill citations
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93).
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostics regulatory reform; price transparency requirements for clinical laboratory services.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.